BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 25, 2019
View Archived Issues
Anti-influenza drug candidate targeting the hemagglutinin stalk of influenza viruses
Read More
Flavonoid baicalin upregulates miR-126-5p: a potential therapeutic strategy against atherosclerosis
Read More
Hypertensive rats are more sensitive to TRPM8-mediated relaxation of the pudendal artery
Read More
Heterozygous COL4A1 mutations are a potential autosomal dominant cause of CAKUT
Read More
Circular RNA hsa_circ_0006848 identified as a potential diagnostic biomarker of early gastric cancer
Read More
Phage-based nanoligands wrap up drugs for delivery across BBB
Read More
Pliant enters collaboration and license agreement with Novartis for PLN-1474 in NASH
Read More
Interim results from phase I trial of chimeric HA-based universal influenza virus vaccine candidates
Read More
First patient dosed in phase IIb ReNeu study of mirdametinib in children and adults with NF1-PN
Read More
FDA approves Botox for pediatric patients with lower limb spasticity
Read More
Scynexis announces amendment to protocol for ongoing FURI study of ibrexafungerp
Read More
EphB4 as a novel biomarker of imatinib resistance in CML
Read More
Researchers identify 7B2CT as potential biomarker in chronic OA pain
Read More
Serum chemerin shows potential as marker to diagnose and grade NAFLD
Read More
SUVN-1702012 for psychiatric disorders balancing antipsychotic and motor side effects
Read More
New glutamate receptor modulator DT-095435 shows impressive in vivo antiparkinsonian potential
Read More
Aurigene Discovery Technologies divulges CDK12 and CDK13 inhibitors
Read More
Janssen Pharmaceutica presents new ionotropic glutamate GluN2B receptor antagonists
Read More
AbbVie and Galapagos identify mutant CFTR correctors for cystic fibrosis
Read More
Merck KGaA synthesizes new IRAK inhibitors
Read More
Japan Tobacco describes new SLC5A1 inhibitors
Read More
Syros reports new data from phase II trial of SY-1425 in newly diagnosed unfit AML
Read More
New phase I trial investigates MB-108 in recurrent glioblastoma multiforme
Read More
NIAID awards contract to UAB to study Bexsero for gonorrhea prevention
Read More
FDA approves Baxdela for community-acquired bacterial pneumonia
Read More
European Commission approves Xospata for relapsed or refractory FLT3 mutation-positive AML
Read More
FDA clears IND for phase I trial of SQZ-PBMC-HPV
Read More